Avanos Medical (AVNS) Short term Debt (2013 - 2026)

Avanos Medical (AVNS) has 9 years of Short term Debt data on file, last reported at $10.9 million in Q1 2026.

• For the quarter ending Q1 2026, Short term Debt rose 15.96% year-over-year to $10.9 million; the trailing twelve-month figure through Mar 2026 stood at $10.9 million (up 15.96% YoY), and the FY2025 full-year result was $10.2 million, up 8.51% from the prior year.
• Short term Debt advanced to $10.9 million in Q1 2026, from $10.2 million in the prior quarter.
• In the past five years, Short term Debt ranged from a high of $10.9 million in Q1 2026 to a low of $4.7 million in Q2 2022.
• A 5-year average of $8.2 million and a median of $9.4 million in 2024 frame the typical range for Short term Debt.
• Across the five-year window, Short term Debt surged 64.52% in 2024 and declined 7.84% in 2025, its largest moves.
• Tracing AVNS's Short term Debt over 5 years: stood at $6.2 million in 2022, then soared by 38.71% to $8.6 million in 2023, then grew by 9.3% to $9.4 million in 2024, then gained by 8.51% to $10.2 million in 2025, then rose by 6.86% to $10.9 million in 2026.
• Business Quant data shows AVNS's Short term Debt at $10.9 million in Q1 2026, $10.2 million in Q4 2025, and $9.4 million in Q3 2025.